Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene

Current Opinion in Rheumatology

Volumn 15, Issue 3, 2003, Pages 326-331

  Williams, Charlene J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM DERIVATIVE; PYROPHOSPHORIC ACID DERIVATIVE;

FAMILIAL DISEASE; GENE; GENE ANKH; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; HEREDITY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHROPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

ANIMALS; CALCINOSIS; CALCIUM PYROPHOSPHATE; CHONDROCALCINOSIS; CHROMOSOMES, HUMAN, PAIR 5; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; PEDIGREE; PHOSPHATE TRANSPORT PROTEINS; RATS; RISK ASSESSMENT;

EID: 0038070134     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200305000-00023     Document Type: Review

References (43)

1. Zitnan D, Sitaj S: Mnohopocentna familiarna kalcifikacin articularnych chrupiek. Bratisl Lek Listy 1958, 38:217-228.
2. Zitnan D, Sitaj S: Chondrocalcinosis articularis. I. Clinical and radiologic study. Ann Rheum Dis 1963, 22:142-169.
3. McCarty DJ, Hollander JL: Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961, 54:452-460.
4. Louyot P, Peterschmitt J, Barthelme P: Chondrocalcinose articulaire diffuse familiale. Rev Rhum 1964, 31:659-663.
5. Moskowitz RW, Katz D: Chondrocalcinosis (pseudogout syndrome): a family study. JAMA 1964, 188:867-871.
6. van der Korst JK, Geerards J, Driessens FCM: A hereditary type of idiopathic articular chondrocalcinosis. Am J Med 1974, 56:307-314.
7. Reginato AJ, Hollander JL, Martinez V, et al.: Familial chondrocalcinosis in the Chiloe Islands, Chile. Ann Rheum Dis 1975, 34:260-268.
8. Gaucher A, Faure G, Netter P, et al.: Hereditary diffuse articular chondrocalcinosis. Dominant manifestation without close linkage with the HLA system in a large pedigree. Scan J Rheumatol 1977, 6:217-221
9. Gaudreau A, Camerlain, M, Piborot ML, et al.: Familial articular chondrocalcinosis in Quebec. Arthritis Rheum 1981, 24:611-615.
10. Bjelle AO: Pyrophosphate arthropathy in two Swedish families. Arthritis Rheum 1982, 25:66-74.
11. Sakaguchi M, Ishikawa K, Mizuta H, et al.: Familial pseudogout with destructive arthropathy. Ryumachi 1982, 22:4-13.
12. Richardson BC, Chafetz NI, Ferrell LD, et al.: Hereditary chondrocalcinosis in a Mexican-American family. Arthritis Rheum 1983, 26:1387-1396.
13. Fernandez-Dapica MP, Gomez-Reino J: Familial chondrocalcinosis in the Spanish population. J Rheumatol 1986, 13:631-633.
14. Rodriguez-Valverde V, Zuffiga M, Casanueva B, et al.: Hereditary articular chondrocalcinosis: clinical and genetic features in 13 pedigrees. Am J Med 1988, 84:101-106.
15. Balsa A, Martin-Mola E, Gonzalez T, et al.: Familial articular chondrocalcinosis in Spain. Ann Rheum Dis 1990, 49:531-535.
16. Eshel G, Gulik A, Halperin N, et al.: Hereditary chondrocalcinosis in an Ashkenazi Jewish family. Ann Rheum Dis 1990, 49:528-530.
17. Doherty M, Hamilton E, Henderson J, et al.: Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families. Br J Rheumatol 1991, 30:10-15.
18. Hamza M, Meddeb N, Bardin T: Hereditary chondrocalcinosis in a Tunisian family. Clin Exp Rheumatol 10:43-49.
19. Riestra JL, Sanchez A, Rodriquez-Valverde V, et al.: Radiographic features of hereditary articular chondrocalcinosis: a comparative study with the sporadic type. Clin Exp Rheumatol 1988, 6:369-372.
20. Ryan LM, McCarty DJ: Calcium pyrophosphate crystal deposition disease; pseudogout; articular chondrocalcinosis. In Arthritis and Allied Conditions. Editied by McCarty DJ, Koopman WJ. Philadelphia: Lea & Febiger; 1993:1835-1855.
21. Williams CJ, Considine EL, Knowlton RG, et al.: Spondyloepiphyseal dysplasia and precocious osteoarthritis in a family with an Arg75→Cys mutation in the procollagen type II gene (COL2A1). Hum Genet 1993, 92:499-505.
22. Baldwin CT, Farrer LA, Adair R, et al.: Linkage of early-onset osteoarthritis and chondrocalcinosis to human chromosome 8q. Am J Hum Genet 1995, 56:692-697.
23. Hughes AE, McGibbon D, Woodward E, et al.: Localisation of a gene for chondrocalcinosis to chromosome 5p. Hum Mol Genet 1995, 4:1225-1228.
24. Andrew LJ, Brancolini V, de al Pena LS, et al: Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease. Am J Hum Genet 1999, 64:136-145
25. Lust G, Faure G, Netter P, et al.: Evidence of a generalized metabolic defect in patients with hereditary chondrocalcinosis: increased inorganic phosphate in cultured fibroblasts and lymphoblasts. Arthritis Rheum 1981, 24:1517-1522.
26. Ho A, Johnson M, Kingsley DM: Role of the mouse ank gene in tissue calcification and arthritis. Science 2000, 289:265-270.
27. Sweet HO, Green MC: Progressive ankylosis, a new skeletal mutation in the mouse. J Hered 1981, 72:87-93.
28. Hakim FT, Cranley R, Brown KS, et al.: Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum 1984, 27:1411-1420.
29. Hakim FT, Brown KS, Oppenheim JJ: Hereditary joint disorder in progressive ankylosis (ank/ank) mice. II. Effect of high dose hydrocortisone treatment on inflammation and intraarticular calcium hydroxyapatite deposits. Arthritis Rheum 1986, 29:114-123.
30. Sampson HW, Davis JS: Histopathology of the intervertebral disc of progressive ankylosis mice. Spine 1988, 13:650-654.
31. Mahowald ML, Krug H, Halverson J: Progressive ankylosis (ank/ank) in mice: an animal model of spondyloarthropathy. II. Light and electron microscopic findings. J Rheumatol 1989, 16:60-66.
32. Terkeltaub RA: Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol 2001, 281:C1-C11.
33. Guo Y, Hsu DK, Feng SL, et al.: Polypeptide growth factors and phorbol ester induce progressive ankylosis (ank) gene expression in murine and human fibroblasts. J Cell Biochem 2001, 84:27-38. This article describes FGF-1 induction of ank expression in mouse and human embryonic lung fibroblasts.
34. Sohn P, Crowley M, Slattery E, et al.: Developmental and TGF-β-mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthritis Cartilage 2002, 10:482-490. This article describes transforming growth factor β regulation of ank/ANKH expression in mouse cartilage and bone.
35. Rosenthal AK, Cheung HS, Ryan LM: Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage. Arthritis Rheum 1991, 34:904-911.
36. Rosenthal AK, Ryan LM: Probenecid inhibits transforming growth factor beta 1 induced pyrophosphate elaboration by chondrocytes. J Rheumatol 1994, 21:896-900.
37. Nurnberg P, Tinschert S, Mrug M, et al.: The gene for autosomal dominant craniometaphyseal dysplasia maps to chromosome 5p and is distinct from the growth hormone receptor gene. Am J Hum Genet 1997, 61:918-923.
38. Nurnberg P, Thiele H, Chandler D, et al.: Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet 2001, 28:37-41.
39. Reichenberger E, Tiziani V, Watanabe S, et al.: Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANKH. Am J Hum Genet 2001, 68:1321-1326.
40. Pendleton A, Johnson MD, Hughes A, et al.: Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 2002, 71:933-940. This article describes ANKH mutations in British and French families.
41. Williams CJ, Zhang Y, Timms A, et al.: Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am J Hum Genet 2002, 71:985-991. This article describes ANKH mutation in an Argentinean family.
42. Ryan LM, Kurup IV, Derfus BA, et al.: ATP-induced chondrocalcinosis. Arthritis Rheum 1992, 35:1520-1525.
43. Ryan LM: The ank gene story. Arthritis Res 2000, 3:77-79.